COPD-related morbidity and mortality after smoking cessation: Status of the evidence

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 844-853

  Godtfredsen, N S ^a,b,c,k   Lam, T H ^d   Hansel, T T ^e   Leon, M E ^g   Gray, N ^g,h   Dresler, C ^g,i   Burns, D M ^g,j   Prescott, E ^c   Vestbo, J ^b,f,k  

^a The Capital Region   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f WYTHENSHAWE HOSPITAL   (United Kingdom)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^h Cancer Council   (Australia)

ⁱ ARKANSAS DEPARTMENT OF HEALTH   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

Chronic obstructive pulmonary disease; Morbidity; Mortality; Review; Smoking cessation

Indexed keywords

CANCER RISK; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SELF REPORT; SMOKING CESSATION; SMOKING HABIT; SURVIVAL RATE; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 58849113557     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00160007     Document Type: Review

References (64)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773.
2. World Health Organization. Chronic Respiratory Diseases. Burden. www.who.int/respiratory/copd/burden/en Date last accessed: June 1, 2008. Date last updated: May 20, 2008.
3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ ERS position paper. Eur Respir J 2004; 23: 932-946.
4. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
5. Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 2007; 175: 1222-1232.
6. Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23: 464-476.
7. 1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
8. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
9. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-390.
10. US Department of Health and Human Services. The Health Benefits of Smoking Cessation: a Report of the Surgeon General. DHHS Publication No. (CDC) 90-8416. Rockville, US Department of Health and Human Services, Public Health Service, Center for Chronic Disease Prevention and Health Control, Office on Smoking and Health, 1990.
11. International Agency for Research on Cancer, World Health Organization. Handbooks of Cancer Prevention. Volume 11. Tobacco Control. Reversal of Risk After Quitting Smoking. Lyon, International Agency for Research on Cancer, 2007.
12. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 14-20.
13. Hughes JA, Hutchison DC, Bellamy D, Dowd DE, Ryan KC, Hugh-Jones P. The influence of cigarette smoking and its withdrawal on the annual change of lung function in pulmonary emphysema. Q J Med 1982; 51: 115-124.
14. Postma DS, De Vries K, Koeter GH, Sluiter HJ. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis 1986; 134: 276-280.
15. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
16. Buist AS, Nagy JM, Sexton GJ. The effect of smoking cessation on pulmonary function: a 30-month follow-up of two smoking cessation clinics. Am Rev Respir Dis 1979; 120: 953-957.
17. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-339.
18. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the Lung Health Study. Am J Respir Crit Care Med 2001; 164: 358-364.
19. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med 2007; 101: 1305-1312.
20. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 158-164.
21. Garcia-Aymerich J, Monso E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001; 164: 1002-1007.
22. Burchfiel CM, Marcus EB, Curb JD, et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med 1995; 151: 1778-1785.
23. Pelkonen M, Notkola I-L, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax 2001; 56: 703-707.
24. 1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD 2007; 4: 5-13.
25. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006; 173: 985-990.
26. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax 2006; 61: 472-477.
27. Tashkin DP, Clark VA, Coulson AH, et al. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. Am Rev Respir Dis 1984; 130: 707-715.
28. Sherrill DL, Holberg CJ, Enright PL, Lebowitz MD, Burrows B. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994; 149: 591-597.
29. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002; 57: 967-972.
30. Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005; 127: 1544-1552.
31. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935-939.
32. Rogot E, Murray JL. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep 1980; 95: 213-222.
33. Kanner RE, Renzetti AD Jr, Stanish WM, Barkman HW Jr, Klauber MR. Predictors of survival in subjects with chronic airflow limitation. Am J Med 1983; 74: 249-255.
34. Postma DS, Gimeno F, van der Weele LT, Sluiter HJ. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility. Eur J Respir Dis 1985; 67: 360-368.
35. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239.
36. Hersh CP, DeMeo DL, Al Ansari E, et al. Predictors of survival in severe, early onset COPD. Chest 2004; 126: 1443-1451.
37. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309: 901-911.
38. Ben Shlomo Y, Smith GD, Shipley MJ, Marmot MG. What determines mortality risk in male former cigarette smokers? Am J Public Health 1994; 84: 1235-1242.
39. Carstensen JM, Pershagen G, Eklund G. Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25,000 Swedish men. J Epidemiol Community Health 1987; 41: 166-172.
40. Kuller LH, Ockene JK, Meilahn E, Wentworth DN, Svendsen KH, Neaton JD. Cigarette smoking and mortality. MRFIT Research Group. Prev Med 1991; 20: 638-654.
41. Marcus EB, Buist AS, Maclean CJ, Yano K. Twenty-year trends in mortality from chronic obstructive pulmonary disease: the Honolulu Heart Program. Am Rev Respir Dis 1989; 140: S64-S68.
42. Tockman MS, Comstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 1989; 140: S56-S63.
43. Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K. Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years. J Clin Epidemiol 1993; 46: 475-487.
44. Sunyer J, Lamarca R, Alonso J. Smoking after age 65 years and mortality in Barcelona, Spain. Am J Epidemiol 1998; 148: 575-580.
45. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relationship of the type of tobacco and inhalation pattern to pulmonary and total mortality. Eur Respir J 1992; 5: 1111-1117.
46. Pelkonen M, Tukiainen H, Tervahauta M, et al. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax 2000; 55: 746-750.
47. Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 2002; 156: 994-1001.
48. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999; 9: 297-306.
49. Engstrom G, Hedblad B, Janzon L, Valind S. Respiratory decline in smokers and ex-smokers - an independent risk factor for cardiovascular disease and death. J Cardiovasc Risk 2000; 7: 267-272.
50. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58: 388-393.
51. Ho SC, Zhan SY, Tang JL, Chan SG, Woo J. Smoking and mortality in an older Chinese cohort. J Am Geriatr Soc 1999; 47: 1445-1450.
52. Hsu HC, Pwu RF. Too late to quit? Effect of smoking and smoking cessation on morbidity and mortality among the elderly in a longitudinal study. Kaohsiung J Med Sci 2004; 20: 484-491.
53. Lam TH, He Y, Shi QL, et al. Smoking, quitting, and mortality in a Chinese cohort of retired men. Ann Epidemiol 2002; 12: 316-320.
54. Lam TH, Li ZB, Ho SY, et al. Smoking, quitting and mortality in an elderly cohort of 56,000 Hong Kong Chinese. Tob Control 2007; 16: 182-189.
55. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
56. Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. BMJ 1980; 280: 967-971.
57. Ebi-Kryston KL. Predicting 15 year chronic bronchitis mortality in the Whitehall Study. J Epidemiol Community Health 1989; 43: 168-172.
58. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-814.
59. Gamble E, Grootendorst DC, Hattotuwa K, et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J 2007; 30: 467-471.
60. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
61. Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J 2006; 28: 781-785.
62. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245-1257.
63. Sin DD, Wu L, Anderson JA, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60: 992-997.
64. 1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest 2007; 131: 682-689.